Overview
Gonyautoxins Local Periarticular Injection for Pain Management After Total Knee Arthroplasty
Status:
Unknown status
Unknown status
Trial end date:
2017-08-01
2017-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this study is to demostrate the eficcacy in pain control management after total knee arthroplasty of Gonyautoxin. Local administration during surgery of Gonyautoxin before wound closure can achieved better pain control and lower morphin use during hospital stay compared to local administration of chirocaine, ketorolac and epinephrinePhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
maximiliano barahona vasquezTreatments:
Epinephrine
Epinephryl borate
Ketorolac
Ketorolac Tromethamine
Levobupivacaine
Racepinephrine
Criteria
Inclusion Criteria:- Patients who required total knee arthroplasty due to knee osteoarthritis ( Kellgren
and Lawrence score of 2 or more), with no response to conservative management.
- Without known allergies to the drugs used in the study
- Anesthetic risk: ASA Score 1,2,3.
Exclusion Criteria:
- Obesity, defined as body Mass index over 35
- Previous Knee surgery
- Mellitus diabetes
- Organic brain damage
- Rheumatic Arthritis
- Coagulation deficit
- Liver disease
- Chronic obstructive pulmonary disease
- Chronic consumption of opiods
- Refusal to participate in the study